Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
97 hedge funds and large institutions have $82.5M invested in Infinity Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 19 closing their positions.
339% more call options, than puts
Call options by funds: $2.88M | Put options by funds: $655K
6% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 32
9% less funds holding
Funds holding: 107 → 97 (-10)
46% less capital invested
Capital invested by funds: $152M → $82.5M (-$69.5M)
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$6.28M |
| 2 |
GC
Gratus Capital
Atlanta,
Georgia
|
+$2.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.93M |
| 4 |
BlackRock
New York
|
+$1.72M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.54M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$5.1M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.35M |
| 4 |
GPC
Guardian Point Capital
Charlottesville,
Virginia
|
-$4.1M |
| 5 |
Two Sigma Investments
New York
|
-$2.43M |
INFI Hedge Fund Activity: Q4 2021 in Review
97 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q4 2021, worth a combined $82.5M — down 46% from $152M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of INFI and 9 opened new positions — a net loss of 10 holders — while 32 trimmed existing stakes and 30 added.
The largest buyer was Polar Capital Holdings, adding an estimated $6.28M. The largest seller was Millennium Management, cutting an estimated $5.54M.
- 97 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q4 2021, down from 107 in Q3 2021.
- Funds reported $82.5M of Infinity Pharmaceuticals, Inc. stock for Q4 2021, down 46% quarter-over-quarter.
- 9 funds opened new Infinity Pharmaceuticals, Inc. positions in Q4 2021 and 19 closed out, a net change of -10 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q4 2021 was Polar Capital Holdings, an estimated $6.28M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q4 2021 was Millennium Management, an estimated $5.54M sold.
Based on aggregated 13F filings for Q4 2021.